CBD for Peripheral Neuropathy: How Does It Work?
by Bethan Rose
Research in the cannabis industry is vital and should not be undervalued. Cannabis research is a systematic investigation into cannabis in order to establish facts as well as to reach new conclusions. Researchers have to follow predetermined procedures and they have to remain as objective as humanly positive. But how does it work? Who or what agencies fund the research? Is there any bias that could potentially sway the results?
With the increase in legalization, use, and acceptance of the plants, our understanding of the plant needs to increase too. The increase in legalization has meant that the research can become more progressive as skilled professionals and resources become more available for the understanding of this plant. There is still much that we don’t know, yet there is so much that we do know.
Research that involves the direct use or possession of cannabis in any form can be conducted if the researcher:
Please note that this process is based on cannabis containing hemp with no more than 0.3% THC on the dry weight basis.
*IND =Investigational new drug
**CDER= Centre for Drug Evaluation and Research
The NIH report displayed the following statistics for the years 2014, 2015, 2016 and 2017.
We could never compile a list of ALL the agencies and individuals who have funded or contributed to funding cannabis research. Below are some examples of those who do.
Although one can make a fairly certain assumption on the agenda behind the funding party, we can never be certain as to whether it will sway results due to ethics and obligation. Researchers are obligated to remain ethical and thus remain objective in their findings. Results that are biased in any manner are considered unethical research and should then also be dismissed…which isn’t always the case anyway.
Cannabis’ former reputation as a gateway drug may have been dispelled, but it turns out that there is some element of truth to the rumor: The plant’s progressively evolving status as a normalized medicine in 37 U.S. states and a recreational substance in 18 U.S. states is prompting a wave of change across America’s statehouses….
Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa. Nicknamed “K,” “special K,” “cat valium,” and “vitamin K,” ketamine is…
Austin decriminalized cannabis possession, Vancouver is now home to some not-so-legal magic mushroom shops, and a British woman shared her life-changing medical marijuana journey. Let’s dive into this week’s cannanews. Austin Voters Pass Cannabis Decriminalization Bill Voters in Austin, Texas, have approved Proposition A, a ballot measure that decriminalizes cannabis possession and bans no-knock warrants….
As if losing a limb is not hard enough, experiencing pain in the part of the limb that is no longer there acts as a constant reminder of what has been lost on top of the actual pain. Phantom limb pain (PLP) plagues an estimated 8 out of 10 people who have lost a limb,…
Woody Harrelson’s new dispensary opened for business, Thailand announced its giveaway of 1 million cannabis plants, and Vermont awarded its first cannabis cultivation license. Let’s dive into this week’s cannanews. Woody Harrelson Opens West Hollywood Dispensary Friday the 13th marked the grand opening of actor and cannabis advocate Woody Harrelson’s new dispensary-consumption lounge hybrid, The…
Research reveals that cannabis can impact male reproductive health through reprogramming sperm, which may have implications for any baby born from such…
The worldwide skincare industry, which is projected to inflate to $189.3 billion USD by 2025, could soon be merging more closely with…
There’s no denying the fact that CBD is dominating the wellness landscape. Increasing awareness of the cannabinoid’s medicinal effects is going hand-in-hand…